Faculty Collaboration Database

Changes in body water compartments with diuretic therapy in infants with chronic lung disease. Early Hum Dev 1997 Apr 25;48(1-2):99-107

Date

04/25/1997

Pubmed ID

9131311

DOI

10.1016/s0378-3782(96)01841-5

Scopus ID

2-s2.0-0030908949 (requires institutional sign-in at Scopus site)   15 Citations

Abstract

The effects of diuretic therapy on body water compartments were studied in preterm infants with chronic lung disease. Gestational age of the infants ranged from 24 to 28 weeks, while the median postnatal age at the time of study was 40 days. Infants were randomized to receive furosemide (1.0 mg/kg/day) alone (n = 5) or combined with metolazone (0.2 mg/kg/day, n = 7) for 4 consecutive days. Treatment in both groups produced a significant decrease (P < 0.05) in extracellular water (ECW) without changes in plasma volume, total body water or body weight. The decrease in ECW with furosemide (503 +/- 28 to 446 +/- 19 ml/kg initial body weight) was of similar magnitude to that seen with combined furosemide plus metolazone (522 +/- 30 to 454 +/- 15 ml/kg initial body weight). Water and electrolyte intakes were similar in both groups and unchanged over the course of the study. These findings suggest that in infants with chronic lung disease, diuretic therapy induces intercompartmental shifts in body water, ultimately decreasing interstitial water while preserving PV. Only combined treatment with furosemide plus metolazone produced a significant increase in urine output, confirming the increased efficacy of combination therapy in inducing diuresis.

Author List

Segar JL, Chemtob S, Bell EF

Author

Jeffrey L. Segar MD Professor in the Pediatrics department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Body Water
Chronic Disease
Diuretics
Drug Therapy, Combination
Extracellular Space
Furosemide
Gestational Age
Humans
Infant
Infant, Newborn
Lung Diseases
Metolazone